Webcasts

Wed, Sep 21, 2022 2:00 PM EDT This webinar will review the key considerations and gaps in evaluating freeze/thaw solutions, examine the elements of a dedicated technology center to bridging these gaps and development risks, and explore successful case studies of a technology center optimizing processes and speed-to-market.

Thursday, June 30, 2022 at 11am PST | 1pm CST | 2pm EST As CRISPR based gene editing progresses from research to therapeutic applications, there is a growing need for high quality GMP grade materials, including the Cas9 protein and supporting instruments, and to minimize off target events. This webinar will discuss the development process of a GMP-manufactured Cas9 protein along with causes of off target events and how to minimize risk with high fidelity Cas9 protein.

Aberrant glycosylation of proteins has been implicated in key steps of disease biology, including the hallmarks of cancer as well as inflammation cascades associated with autoimmunity and aging. InterVenn Biosciences harnesses the predictive powers of artificial intelligence combined with cutting edge mass spectrometry to discover clinically relevant biomarkers that can only be revealed by high-resolution analysis of the glycoproteome.

Wednesday, April 13, 2022 at 2pm EST | 1pm CST | 11am PST Selecting raw materials for developing and manufacturing is not a trivial decision. Join us and learn how to avoid mistakes in raw material selection that can delay or prevent a promising mRNA therapeutic or vaccine from reaching the market..

Wednesday, March 30th, 2022 at 11am SST | 2pm AEDT | 10am ICT | 12pm KST Applying the appropriate tools for oligonucleotide purification and subsequent analysis is a unique challenge requiring application specific solutions. Join Drs. Anne Blackwell and Matthew L. Turner of Agilent Technologies for tips on oligonucleotide analysis and purification with Agilent’s suite of Bio LC solutions.

Thursday, March 24, 2022 at 11am EST | 10am CST | 8am PST Advancing size-exclusion chromatography through recent developments in particle technology and hydrophilic surfaces.

Wednesday, March 16th, 2022 at 11am SST | 2pm AEDT | 10am ICT | 12pm KST Please join us for a series of three intense investigations into the practicalities required to define, identify, and explore the functions of important biological molecules including glycans, monoclonal antibodies, and oligonucleotides. We outline cutting edge and mainstay analytic tools and protocols, with multiple case studies and practical examples from world leading experts.

Tuesday, February 22, 2022 at 11am EST Hear from Parker Hannifin’s experts on how they are mitigating risk, while accelerating timelines, with open architecture and greater processing flexibility using custom single-use systems for vaccines, antibodies, therapeutics, and gene and cell therapies.

Tuesday, January, 11th, 2022 at 9am EST | 3pm CET | 2pm GMT Tuesday, January, 11th, 2022 at 2pm EST | 11am PST | 7pm GMToin us in our expert discussion of Rapid Analysis of mRNA 5’ Capping and Poly-A Tailing with High-Resolution LC-MS. See how mRNA capping can be analyzed by LC-MS within 75 minutes!

*Thursday, May 27, 2021 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST* Transportation of your bulk drug substance (BDS) from downstream to the fill/finish site might not be as simple as it sounds. Mostly geographically detached, each batch of BDS is filled into different primary packaging, frozen to sub-zero temperatures, stored, and shipped before it is then thawed and drained at the fill/finish site. *On Demand Until May 27, 2022*

*Tuesday, May 25, 2021 at 10am EDT* The bio/pharma industry is turning to proven digital technologies used in other industries to plan, develop, and monitor manufacturing processes, as well as in quality, training, and regulatory oversight. In this event, experts discuss how artificial intelligence, remote monitoring, digital twins, and other technologies can be applied to modernize bio/pharma processes and systems. Lessons learned from the pandemic will be shared. *On Demand Until May 25, 2022*

***Live Tuesday, April 13, 2021 at 11am EDT| 8am PDT| 4pm BST| 5pm CEST** Designing a successful stability program can go a long way towards getting your drug product or substance to market. Join this webinar to receive guidance on designing stability testing programs and overcoming potential challenges. *On Demand until April 13, 2022*

***Available Now!*** In this webinar, Mike Knierman, Eli Lilly, will discuss the use of mass spectrometry to identify unique sequences from SARS-CoV-2 spike glycoprotein extracellular domain in a complex with human leukocyte antigen class II molecules on antigen presenting cells from healthy donors. This work exemplifies the value-add of mass spectrometry in vaccine development. *On Demand until March 30, 2022*